Ligand · LM3
LM3 · N,N-dimethyl-6-(naphthalen-1-yl)-5-(pyridin-4-yl)pyridazin-3-amine
LM3, N,N-dimethyl-6-(naphthalen-1-yl)-5-(pyridin-4-yl)pyridazin-3-amine (C21 H18 N4, 326.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å, the residues it…
- Component
- LM3
- Formula
- C21 H18 N4
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
LM3 in 2 structures; the first of them:
- 4F9Y · Human P38 alpha MAPK In Complex With a Novel and Selective Small Molecule Inhibitor · LM3 A403 · binds VAL38, ALA51, VAL52, LYS53, LEU75, ILE84, LEU86, LEU104 and 9 more
- 4F9Y · Human P38 alpha MAPK in complex with a novel and selective small molecule inhibitor · LM3 A403 · binds VAL38, ALA51, VAL52, LYS53, LEU75, ILE84, LEU86, LEU104 and 9 more
Residues it binds most
LEU 2, VAL 2, ALA 2, ASN 2, ASP 2, HIS 2, ILE 2, LYS 2, MET 2, SER 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.